Literature DB >> 28167689

Yamaguchi syndrome presenting as atrioventricular nodal re-entrant tachycardia in an African-American patient.

Nellowe Candelario1, Jorge Penalver1, Mitali Sen1.   

Abstract

Apical hypertrophic cardiomyopathy (Yamaguchi syndrome) is a rare subtype of hypertrophic cardiomyopathy. The syndrome is more common in Japan where it was first described. Outside Asia, it is a very rare cause of hypertrophic cardiomyopathy. Apical hypertrophic cardiomyopathy is usually detected incidentally and has a good long-term outcome. We present a case of apical hypertrophic cardiomyopathy in an African-American patient manifesting as atrioventricular nodal re-entrant tachycardia. 2017 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 28167689      PMCID: PMC5293975          DOI: 10.1136/bcr-2016-218051

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  24 in total

1.  Long-term outcome in patients with apical hypertrophic cardiomyopathy.

Authors:  Maria J Eriksson; Brian Sonnenberg; Anna Woo; Paul Rakowski; Thomas G Parker; E Douglas Wigle; Harry Rakowski
Journal:  J Am Coll Cardiol       Date:  2002-02-20       Impact factor: 24.094

2.  Fatal potential of supraventricular tachycardia in hypertrophic cardiomyopathy.

Authors:  Miroslav J Munclinger; Andrew S Thornton; Daniel P Schutte; Karen Sliwa
Journal:  Int J Cardiol       Date:  2004-02       Impact factor: 4.164

Review 3.  Apical hypertrophic cardiomyopathy (apical hypertrophy): an overview.

Authors:  T Sakamoto
Journal:  J Cardiol       Date:  2001       Impact factor: 3.159

Review 4.  Hypertrophic cardiomyopathy: a systematic review.

Authors:  Barry J Maron
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

5.  Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.

Authors:  Carsten Rickers; Norbert M Wilke; Michael Jerosch-Herold; Susan A Casey; Prasad Panse; Neeta Panse; Jochen Weil; Andrey G Zenovich; Barry J Maron
Journal:  Circulation       Date:  2005-08-09       Impact factor: 29.690

6.  Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.

Authors:  B J Maron; I Olivotto; P Spirito; S A Casey; P Bellone; T E Gohman; K J Graham; D A Burton; F Cecchi
Journal:  Circulation       Date:  2000-08-22       Impact factor: 29.690

7.  Eectrophysiological observations in pateints with rate dependent bundle branch block.

Authors:  P Denes; D Wu; R C Dhingra; F Amat-y-leon; C Wyndham; K M Rosen
Journal:  Circulation       Date:  1975-02       Impact factor: 29.690

8.  Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography.

Authors:  J C C Moon; N G Fisher; W J McKenna; D J Pennell
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

9.  Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States.

Authors:  Hiroaki Kitaoka; Yoshinori Doi; Susan A Casey; Nobuhiko Hitomi; Takashi Furuno; Barry J Maron
Journal:  Am J Cardiol       Date:  2003-11-15       Impact factor: 2.778

10.  Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasono-cardiotomographic study.

Authors:  T Sakamoto; C Tei; M Murayama; H Ichiyasu; Y Hada
Journal:  Jpn Heart J       Date:  1976-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.